Australia & New Zealand market, in cold laser therapy are significantly expanding. With rate of 4.7%, the market will reach to 4.4 million in 2035 from 2.8 million in 2025.
| Attributes | Values |
|---|---|
| Estimated Australia & New Zealand Industry Size (2025) | 2.8 million |
| Projected Australia & New Zealand Value (2035) | 4.4 million |
| Estimated CAGR (2025 to 2035) | 4.7% |
Cold Laser Therapy has been predominantly adopted in Australia and New Zealand to treat chronic musculoskeletal pain as well as sport injuries. Further rising advancement in multi-wavelength systems and portable devices propel the market growth.
Furthermore, increased awareness on the part of patients and healthcare providers about the merits of cold laser therapy enhance its appeal across hospitals, Innovative technologies, such as multi-wavelength systems, portable units, and other equipment modifications, broaden its versatility and make it accessible to a wide range of conditions and patient needs.
Portable cold laser devices are found to be highly in demand in homecare settings, offering patients the comfort of managing chronic conditions on their own and therefore avoiding continuous clinical visits.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The table below offers a detailed comparative assessment of the changes in the compound annual growth rate (CAGR) over six months for the base year (2024) and the current year (2025) specifically for the Australia & New Zealand cold laser therapy market.
This semi-annual analysis highlights all the critical shifts of market dynamics as well as details the revenue realization pattern, thus more precisely providing to the stakeholders insight into the trajectory of growth within a year. In other words, H1 contains January to June, and the other half H2 contains July to December.
H1 signifies period from January to June, H2 Signifies period from July to December
The cold laser therapy sector for the Australia & New Zealand market is expected to rise at 5.0% growth rate in the first half of 2024, which will increase to 5.3% in the second half of the same year. In 2025, the growth rate is expected to slightly decline to 4.7% in H1 but is expected to rise to 5.5% in H2.
This pattern shows a decline of 26.0 basis points from the first half of 2024 to the first half of 2025, while in the second half of 2024, it is higher by 22.0 basis points compared to the second half of 2024.
The nature of the Australia & New Zealand cold laser therapy market is cyclical, with periodic shifts in government regulations, healthcare reforms, and patient needs. The performance review will, on a six-monthly basis, help any business stay competitive and correct course in changing market dynamics.
| Date | Development/M&A Activity & Details |
|---|---|
| 2025 | Product Approvals: Apollo focuses on gaining approval from different regulatory bodies. All products of the company have FDA, CE, TGA, Health Canada, and NATO clearances. |
| 2024 | Innovation: B-Cure Laser Australia, LLC Erchonia Corporation focuses on expanding its presence in the global market. |
| 2024 | Expansion: MICROLIGHT Corporation focuses on launching innovative products to widen its presence in the market by targeting more customers. |
Rising Adoption in Pain Management and Rehabilitation
It is the one type of treatment employed in Australia and New Zealand for chronic pain conditions like arthritis, back pain, and neuropathy. The cold laser therapy stands to be a favorite treatment for treating such conditions since it has been known to abolish pain and cure conditions without invasive procedures or drugs.
Focus on Sports Medicine and Physiotherapy
Australia and New Zealand are two countries that have very active lifestyles and robust sports culture. It is the main reason behind the growing trend of cold laser therapy in sports medicine. Recovery is faster, circulation is better, and inflammation decreases, making this therapy a must in physiotherapy and sports rehabilitation.
Advancements in Portable and Multi-Wavelength Devices
Portable cold laser units are now enabling therapy to become more accessible from homecare, while multiwavelength systems find their place within clinics and hospitals because they offer the ability to treat more conditions at once.
% share of Individual categories by Product Type and End User in 2025
Continuous laser devices records significant surge in cold laser therapy market
Continuous devices dominate the market in Australia and New Zealand, given their proven efficacy in pain management, rehabilitation of sports injuries, and various physiotherapy treatments. They offer consistent laser output for correct and predictable therapeutic outcomes in arthritis, soft tissue injuries, and chronic pain conditions.
High participation in sports across the two countries, coupled with increasing musculoskeletal problems among an aging population, have driven the demand for non-invasive modes of treatment. In addition, the advancement of laser technology with portable and user-friendly designs increases the rate of adoption in both professional clinics and homecare.
Specialty clinics are, therefore, considered the largest end-user segment of cold laser therapy in Australia and New Zealand markets, especially physiotherapy, chiropractic, and sports medicine. These focus highly on the prevention of injuries, rehabilitation, and pain management without the use of drugs, and thus have widely adopted continuous laser devices for treating patients.
This demand has been further driven by the growing awareness of alternative solutions for pain management and the rise in sports and rehabilitation centers. Besides, the integration of cold laser therapy into holistic and wellness-oriented treatment options has contributed to the market growth in line with the emphasis on non-invasive and patient-centric healthcare in the region.
Note: above chart is indicative in nature
Competition in the cold laser therapy market of Australia and New Zealand is driven by key players like Erchonia Corporation, DJO Global, Inc., BTL, THOR Photomedicine Ltd, and BioLight Technologies LLC, which dominate the market by means of technological innovation and strong regulatory compliance.
These Tier 1 companies focus on developing high-performance, clinically validated low-level laser therapy (LLLT) devices that meet the stringent medical standards of the region. Their research and development activities, linked with close cooperation with healthcare providers, have secured leadership positions in both professional and consumer markets.
Meanwhile, Tier 2 companies such as Irradia, Omega Laser Systems, and Multi Radiance Medical are gaining ground by offering cost-effective and accessible solutions for mid-sized clinics and home-use applications.
These companies further create portable, user-friendly LLLT devices that meet the growing demand for pain relief and rehabilitation from home. Their niche offers competitive, value-for-money treatments for musculoskeletal conditions, post-injury recovery, and chronic pain, while Australia and New Zealand have a growing interest in self-care and other alternative therapy solutions.
The industry includes various product type such as continuous laser devices pulse laser devices and combination laser devices
The industry includes various materials such as single wavelength cold laser therapy devices, multiple wavelength cold laser therapy devices.
The industry includes various indications such as pain management, arthritis wound healing, nerve regeneration, dermatology, musculoskeletal and others
Available in end user like hospitals, specialty clinics, ambulatory surgical centers, and homecare settings.
The market is expected to grow at a CAGR of 4.7% from 2025 to 2035.
Continuous laser devices are the leading products in the market.
Key players include Apira Science Inc, BioLight Technologies LLC, B-Cure laser Australia, Erchonia Corporation, Theralase Inc., THOR Photomedicine Ltd, DJO Global, Inc., BTL, Spectro Analytic Irradia AB, and Photomedex.
Explore Therapeutic Device Insights
View Reports
Australia and New Zealand Cold Laser Therapy Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
